Drug profile · INN
trafermin
REGROTH
trafermin (REGROTH) is a fibroblast growth factor receptor 2 agonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — trafermin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
trafermin (REGROTH) is a fibroblast growth factor receptor 2 agonist.
Key facts
INN trafermin
Brand REGROTH
Mechanism Fibroblast growth factor receptor 2 agonist
Target Fibroblast growth factor receptor 2
Mechanism of action
Fibroblast growth factor receptor 2 agonist
Primary target: Fibroblast growth factor receptor 2
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trafermin?
trafermin (REGROTH) is a fibroblast growth factor receptor 2 agonist.
What is the brand name for trafermin?
REGROTH is a marketed brand name for trafermin. Check FDA Drugs@FDA for the current US label holder and prescribing information.